Table 4.

Gastric cancer, intestinal metaplasia, and neutrophil infiltration in propensity score–matched patients with NSAIDs

NSAID useNonuse
n = 898 (%)n = 898 (%)P
Gastric cancer0 (0)3 (0.33)0.250
 Diffuse-type0 (0)1 (0.11)1.000
 Intestinal-type0 (0)2 (0.22)0.500
Intestinal metaplasiaa,b367 (42.58)344 (39. 91)0.261
 Antrum311 (36.00)293 (33.79)0.337
 Corpus132 (15.12)121 (14.04)0.523
Neutrophil infiltrationa,b388 (45.27)428 (49.94)0.053
 Antrum266 (30.86)314 (36.38)0.015
 Corpus351 (40.72)367 (42.82)0.376
  • NOTE: Bold indicates statistical significance (P < 0.05).

  • aAllows duplicated.

  • bIncludes missing data.